This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Holdings Co., Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Innovations of Ji Hyeon Gong in Cancer Research
Introduction
Ji Hyeon Gong is a notable inventor based in Osan-si, South Korea. He has made significant contributions to the field of cancer research through his innovative work on quinazoline derivatives. His research focuses on developing compounds that can inhibit cancer cell growth, which is crucial in the fight against cancer.
Latest Patents
Ji Hyeon Gong holds a patent for "Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof." This invention relates to a novel quinazoline derivative and a pharmaceutically acceptable salt that can effectively inhibit the growth of cancer cells. The patent also includes a method for preparing these derivatives and a pharmaceutical composition that comprises them as an active ingredient.
Career Highlights
Gong is currently associated with Hanmi Holdings Co., Ltd., a prominent company in the pharmaceutical industry. His work at Hanmi has allowed him to focus on developing innovative solutions for cancer treatment, contributing to the advancement of medical science.
Collaborations
Some of his coworkers include Young Jin Ham and Mi Young Cha, who collaborate with him on various research projects. Their combined expertise enhances the potential for groundbreaking discoveries in the field of oncology.
Conclusion
Ji Hyeon Gong's contributions to cancer research through his innovative patents highlight the importance of scientific advancements in medicine. His work continues to inspire future research and development in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile